Search
-
News
A new type of cancer therapy that targets an oncometabolite produced dramatic results in patients with advanced leukemia in an early-phase clinical trial.
… Sunday, December 7, 2014 A new type of cancer therapy that targets an oncometabolite produced dramatic results in patients with advanced leukemia in an early-phase clinical trial. The study, led by Eytan M. Stein, MD , a medical oncologist at Memorial Sloan Kettering Cancer Center, was presented today
-
Maxillofacial ProsthodontistI am a board-certified prosthodontist who specializes in creating prosthetics to replace missing tissue in the jaws and face. I have been in practice for more than 20 years. I have experience caring for people with cancer and those who have complex restorative or other maxillofacial prosthetic needs. I work closely with Memorial Sloan Kettering’s Ophthalmology Department to create prostheses for the eyes.
… Maxillofacial Prosthodontist Job Title Director, Maxillofacial Prosthetics I am a board-certified prosthodontist who has special training in creating prosthetics to replace missing tissue in the jaws and face. I have been in practice for more than 20 years. I have experience in caring for people with
-
Maxillofacial ProsthodontistSoy prostodoncista certificado por la junta, especializado en crear prótesis para reemplazar el tejido que falta en la mandíbula y en la cara. Llevo más de 20 años de ejercicio en la profesión. Tengo experiencia en el cuidado de personas con cáncer y de aquellas que tienen necesidades complejas de restauración u otras necesidades protésicas maxilofaciales. Trabajo en conjunto con el Servicio de Oftalmología del Memorial Sloan Kettering para crear prótesis para los ojos.
… Maxillofacial Prosthodontist Job Title Director, Prótesis Maxilofacial Soy prostodoncista certificado por la junta y cuento con formación especializada en la creación de prótesis para reemplazar el tejido que falta en la mandíbula y en la cara. Llevo más de 20 años de ejercicio en la profesión. Tengo
-
-
Radiation Oncology Residency
… A Research Hub of the Radiation Oncology Residency Program Welcome to HIGHER, the principal research center devoted to addressing disparities in cancer care outcomes. Our mission is to advance health implementation strategies and promote global health equity through robust data analysis, strategic community
-
News
Researchers at MSK have been at the forefront of developing new treatments for advanced melanoma for many years. Learn more about the latest therapies.
… Monday, July 8, 2024 In recent years, advanced melanoma (a type of skin cancer) has been transformed from a disease that was almost always fatal to one that often can be brought under control for years, or even cured. Thanks to new drugs, people with advanced disease have a five-year survival rate of
-
-
… Job Title Program Assistant
-
The Mary Baylies Lab
-
Technology Development
… Description SK-RC-18 is a metastatic renal clear cell carcinoma cell line derived from the cervical lymph node which grows in both nude mice and soft agar. This is cell line is part of a collection of renal cell carcinoma (RCC) cell lines derived from metastatic sites of patients who underwent surgery